YS10
YS10 is a Tryptamine (HY-B2132) derivative. YS10 inhibits cell viability of SH-SY5Y cells with an IC50 of 0.44 nM[1].
Product Specifications
CAS Number
[3055427-13-6]
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ys10.html
Smiles
O=C1N(C(C2=CC=C(C=C2)F)SC1)CCC3=CNC4=C3C=C(O)C=C4
Molecular Formula
C19H17FN2O2S
Molecular Weight
356.41
References & Citations
[1]Aydın S, et al. Synthesis of Tryptamine-Thiazolidin-4-one Derivatives and the Combined In Silico and In Vitro Evaluation of their Biological Activity and Cytotoxicity. ACS Omega. 2024 Oct 23;9 (44) :44262-44281.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1184858-01 0.02 mg (E-Coli)
Recombinant Clostridium beijerinckii tRNA modification GTPase MnmE (mnmE)
Ask
View Details 
MBS1184858-02 0.02 mg (Yeast)
Recombinant Clostridium beijerinckii tRNA modification GTPase MnmE (mnmE)
Ask
View Details 
MBS1184858-03 0.1 mg (E-Coli)
Recombinant Clostridium beijerinckii tRNA modification GTPase MnmE (mnmE)
Ask
View Details MBS1184858-04 0.1 mg (Yeast)
Recombinant Clostridium beijerinckii tRNA modification GTPase MnmE (mnmE)
Ask
View Details MBS1184858-05 0.02 mg (Baculovirus)
Recombinant Clostridium beijerinckii tRNA modification GTPase MnmE (mnmE)
Ask
View Details 
MBS1184858-06 0.02 mg (Mammalian-Cell)
Recombinant Clostridium beijerinckii tRNA modification GTPase MnmE (mnmE)
Ask
View Details